Morgan Stanley’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,714,813
| Closed | -$26.2M | – | 8339 |
|
|
2025
Q4 | $26.2M | Sell |
1,714,813
-94,609
| -5% | -$1.41M | ﹤0.01% | 2676 |
|
|
2025
Q3 | $26.9M | Sell |
1,809,422
-22,813
| -1% | -$331K | ﹤0.01% | 2593 |
|
|
2025
Q2 | $26.3M | Sell |
1,832,235
-58,331
| -3% | -$812K | ﹤0.01% | 2540 |
|
|
2025
Q1 | $27.4M | Buy |
1,890,566
+7,197
| +0.4% | +$108K | ﹤0.01% | 2371 |
|
|
2024
Q4 | $28.4M | Buy |
1,883,369
+248,939
| +15% | +$3.77M | ﹤0.01% | 2400 |
|
|
2024
Q3 | $24.3M | Buy |
1,634,430
+234,062
| +17% | +$3.36M | ﹤0.01% | 2605 |
|
|
2024
Q2 | $19.6M | Buy |
1,400,368
+26,974
| +2% | +$378K | ﹤0.01% | 2693 |
|
|
2024
Q1 | $20.1M | Sell |
1,373,394
-844,488
| -38% | -$12.2M | ﹤0.01% | 2686 |
|
|
2023
Q4 | $31.1M | Buy |
2,217,882
+1,133,208
| +104% | +$15.4M | ﹤0.01% | 2937 |
|
|
2023
Q3 | $14.9M | Buy |
1,084,674
+152,833
| +16% | +$2.16M | ﹤0.01% | 2755 |
|
|
2023
Q2 | $13.1M | Sell |
931,841
-56,327
| -6% | -$816K | ﹤0.01% | 2909 |
|
|
2023
Q1 | $14.5M | Sell |
988,168
-135,196
| -12% | -$2.05M | ﹤0.01% | 2778 |
|
|
2022
Q4 | $17.4M | Buy |
1,123,364
+167,903
| +18% | +$2.55M | ﹤0.01% | 2483 |
|
|
2022
Q3 | $12.9M | Buy |
955,461
+66,698
| +8% | +$1.03M | ﹤0.01% | 2684 |
|
|
2022
Q2 | $13.6M | Buy |
888,763
+210,619
| +31% | +$3.37M | ﹤0.01% | 2725 |
|
|
2022
Q1 | $11.3M | Sell |
678,144
-24,379
| -3% | -$409K | ﹤0.01% | 2777 |
|
|
2021
Q4 | $12.5M | Sell |
702,523
-175,296
| -20% | -$3.06M | ﹤0.01% | 2688 |
|
|
2021
Q3 | $14.7M | Sell |
877,819
-40,588
| -4% | -$700K | ﹤0.01% | 2432 |
|
|
2021
Q2 | $15.6M | Sell |
918,407
-1,261
| -0.1% | -$21.2K | ﹤0.01% | 2443 |
|
|
2021
Q1 | $14.9M | Buy |
919,668
+116,643
| +15% | +$1.79M | ﹤0.01% | 2226 |
|
|
2020
Q4 | $12.2M | Buy |
803,025
+83,877
| +12% | +$1.2M | ﹤0.01% | 2298 |
|
|
2020
Q3 | $9.73M | Buy |
719,148
+92,831
| +15% | +$1.28M | ﹤0.01% | 2057 |
|
|
2020
Q2 | $8.52M | Sell |
626,317
-28,472
| -4% | -$380K | ﹤0.01% | 2116 |
|
|
2020
Q1 | $8.2M | Sell |
654,789
-58,819
| -8% | -$945K | ﹤0.01% | 1954 |
|
|
2019
Q4 | $12.6M | Buy |
713,608
+5,520
| +0.8% | +$98.3K | ﹤0.01% | 2143 |
|
|
2019
Q3 | $12.6M | Sell |
708,088
-24,496
| -3% | -$432K | ﹤0.01% | 1889 |
|
|
2019
Q2 | $12.9M | Buy |
732,584
+28,957
| +4% | +$511K | ﹤0.01% | 1887 |
|
|
2019
Q1 | $12.7M | Buy |
703,627
+15,750
| +2% | +$277K | ﹤0.01% | 1803 |
|
|
2018
Q4 | $11.1M | Buy |
687,877
+87,084
| +14% | +$1.56M | ﹤0.01% | 2025 |
|
|
2018
Q3 | $11.9M | Buy |
600,793
+83,628
| +16% | +$1.6M | ﹤0.01% | 2242 |
|
|
2018
Q2 | $9.56M | Buy |
517,165
+53,922
| +12% | +$1.01M | ﹤0.01% | 2421 |
|
|
2018
Q1 | $8.23M | Buy |
463,243
+65,333
| +16% | +$1.2M | ﹤0.01% | 2528 |
|
|
2017
Q4 | $7.5M | Buy |
397,910
+50,528
| +15% | +$902K | ﹤0.01% | 2681 |
|
|
2017
Q3 | $5.89M | Buy |
347,382
+72,853
| +27% | +$1.22M | ﹤0.01% | 2777 |
|
|
2017
Q2 | $4.54M | Buy |
274,529
+27,465
| +11% | +$444K | ﹤0.01% | 2951 |
|
|
2017
Q1 | $3.87M | Buy |
247,064
+39,097
| +19% | +$612K | ﹤0.01% | 3138 |
|
|
2016
Q4 | $3.12M | Buy |
207,967
+13,859
| +7% | +$201K | ﹤0.01% | 3491 |
|
|
2016
Q3 | $2.8M | Buy |
194,108
+5,577
| +3% | +$81.7K | ﹤0.01% | 3209 |
|
|
2016
Q2 | $2.74M | Sell |
188,531
-8,249
| -4% | -$117K | ﹤0.01% | 3154 |
|
|
2016
Q1 | $2.78M | Sell |
196,780
-50,538
| -20% | -$678K | ﹤0.01% | 3073 |
|
|
2015
Q4 | $3.55M | Sell |
247,318
-34,443
| -12% | -$491K | ﹤0.01% | 2989 |
|
|
2015
Q3 | $3.8M | Sell |
281,761
-9,290
| -3% | -$133K | ﹤0.01% | 2900 |
|
|
2015
Q2 | $4.32M | Sell |
291,051
-4,483
| -2% | -$68.1K | ﹤0.01% | 2920 |
|
|
2015
Q1 | $4.48M | Buy |
295,534
+15,644
| +6% | +$241K | ﹤0.01% | 2858 |
|
|
2014
Q4 | $4.32M | Buy |
+279,890
| New | +$4.51M | ﹤0.01% | 2863 |
|
Other funds holding DIAX
Morgan Stanley's DIAX Position: Q1 2026 in Review
Morgan Stanley sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 1,714,813 shares — an estimated $26.2M sold.
Morgan Stanley first reported a position in DIAX in Q4 2014 and held it in 45 quarters. The position peaked at $31.1M in Q4 2023. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.
- Morgan Stanley reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
- Morgan Stanley sold 1,714,813 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $26.2M.
- Morgan Stanley first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2014 and held it in 45 quarters.
- Morgan Stanley's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $31.1M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.